Arkolith/Insider Trading/ATNF/Form 4

McGovern Jr. Donald A.

Director180 Life Sciences Corp. (ATNF) · full profile →Form 4 · filed May 23, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 19, 2022Grant(A)12K$1.36$17K51K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 19, 2022Grant(A)134K—$0134K
May 19, 2022Grant(A)15K—$015K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-22-028975) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML